Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle protein 20 homolog B (CDC20B) is a WD40-repeat–containing protein required for centriole release during multiciliated cell differentiation. Unlike the canonical CDC20, which is an activator of the anaphase-promoting complex (APC/C) and a well-known cell cycle regulator, CDC20B lacks the domains necessary for APC/C binding and activation. Instead, it functions in association with deuterosomes and is essential for separating newly formed centrioles from these structures, enabling subsequent cilia production in vertebrate multiciliated cells. CDC20B is specifically expressed during the phase of centriole amplification in maturing MCCs and forms complexes with proteins such as PLK1 and SPAG5 to coordinate the local activation of Separase, the protease necessary for centriole disengagement. Disruption of CDC20B impairs ciliogenesis, highlighting its unique and essential role in multiciliary tissue biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle protein 20 homolog B (CDC20B).